Publications by authors named "Andreas Verras"

Claim this Profile
D
Discovery of a Novel Mutant-Selective Epidermal Growth Factor Receptor Inhibitor Using an Enabled Drug Discovery Platform.
Hideyuki Igawa, Zef A Konst, Eric Therrien, Mee Shelley, Heidi Koldsø, Andreas Verras

J Med Chem· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization and Mechanistic Investigations of Novel Allosteric Activators of PKG1α.
Victor W Mak, Akash M Patel, Rose Yen, Jennifer Hanisak, Yeon-Hee Lim, Andreas Verras

J Med Chem· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural basis for isoform-specific inhibition of human CTPS1.
Eric M Lynch, Michael A DiMattia, Steven Albanese, Gydo C P van Zundert, Jesse M Hansen, Andreas Verras

Proc Natl Acad Sci U S A· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of the First Non-cGMP Mimetic Small Molecule Activators of cGMP-Dependent Protein Kinase 1 α (PKG1α).
Jennifer Hanisak, Aileen Soriano, Gregory C Adam, Andrea Basso, David Bauman, Andreas Verras

ACS Med Chem Lett· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAIP: a web service for predicting blood-stage malaria inhibitors.
Nicolas Bosc, Eloy Felix, Ricardo Arcila, David Mendez, Martin R Saunders, Andreas Verras

J Cheminform· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of indazole mineralocorticoid receptor antagonists and investigation into their selective late-stage functionalization.
Kun Liu, Ravi Kurukulasuriya, Kevin Dykstra, Lisa DiMichelle, Jinchu Liu, Andreas Verras

Bioorg Med Chem Lett· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating the discovery of DGAT1 inhibitors through the application of parallel medicinal chemistry (PMC).
Yang Yu, Zhicai Wu, Zhi-Cai Shi, Shuwen He, Zhong Lai, Andreas Verras

Bioorg Med Chem Lett· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzimidazole-based DGAT1 inhibitors with a [3.1.0] bicyclohexane carboxylic acid moiety.
Shuwen He, Zhong Lai, Qingmei Hong, Jackie Shang, Mikhail Reibarkh, Andreas Verras

Bioorg Med Chem Lett· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of multiple docking and refinement methods in the pose prediction D3R prospective Grand Challenge 2016.
Xavier Fradera, Andreas Verras, Yuan Hu, Deping Wang, Hongwu Wang

J Comput Aided Mol Des· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Workflows and performances in the ranking prediction of 2016 D3R Grand Challenge 2: lessons learned from a collaborative effort.
Ying-Duo Gao, Yuan Hu, Alejandro Crespo, Deping Wang, Kira A Armacost, Andreas Verras

J Comput Aided Mol Des· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Informing the Selection of Screening Hit Series with in Silico Absorption, Distribution, Metabolism, Excretion, and Toxicity Profiles.
John M Sanders, Douglas C Beshore, J Christopher Culberson, James I Fells, Jason E Imbriglio, Andreas Verras

J Med Chem· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Multitask Deep Learning Practical for Pharma?
Bharath Ramsundar, Bowen Liu, Zhenqin Wu, Andreas Verras, Matthew Tudor

J Chem Inf Model· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of indazole aldosterone synthase (CYP11B2) inhibitors as potential treatments for hypertension.
Scott B Hoyt, Jerry Taylor, Clare London, Amjad Ali, Feroze Ujjainwalla, Andreas Verras

Bioorg Med Chem Lett· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microscale High-Throughput Experimentation as an Enabling Technology in Drug Discovery: Application in the Discovery of (Piperidinyl)pyridinyl-1H-benzimidazole Diacylglycerol Acyltransferase 1 Inhibitors.
Tim Cernak, Nathan J Gesmundo, Kevin Dykstra, Yang Yu, Zhicai Wu, Andreas Verras

J Med Chem· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shared Consensus Machine Learning Models for Predicting Blood Stage Malaria Inhibition.
Andreas Verras, Chris L Waller, Peter Gedeck, Darren V S Green, Thierry Kogej

J Chem Inf Model· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Chromane Propionic Acid Analogues as Selective Agonists of GPR120 with Activity in Rodents.
Gregory L Adams, Francisco Velazquez, Charles Jayne, Unmesh Shah, Shouwu Miao, Andreas Verras

ACS Med Chem Lett· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Spirocyclic Aldosterone Synthase Inhibitors as Potential Treatments for Resistant Hypertension.
Whitney L Petrilli, Scott B Hoyt, Clare London, Daniel McMasters, Andreas Verras

ACS Med Chem Lett· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Pharmacology of a Novel Class of Diacylglycerol Acyltransferase 2 Inhibitors.
Jason E Imbriglio, Dong-Ming Shen, Rui Liang, Ken Marby, Ming You, Andreas Verras

J Med Chem· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Triazole CYP11B2 Inhibitors with in Vivo Activity in Rhesus Monkeys.
Scott B Hoyt, Whitney Petrilli, Clare London, Gui-Bai Liang, Jim Tata, Andreas Verras

ACS Med Chem Lett· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Benzimidazole CYP11B2 Inhibitors with in Vivo Activity in Rhesus Monkeys.
Scott B Hoyt, Min K Park, Clare London, Yusheng Xiong, Jim Tata, Andreas Verras

ACS Med Chem Lett· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of sebaceous gland atrophy-sparing DGAT1 inhibitors.
Eric S Muise, Yonghua Zhu, Andreas Verras, Bindhu V Karanam, Judith Gorski

PLoS One· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrazoles as non-classical bioisosteres in prolylcarboxypeptidase (PrCP) inhibitors.
Thomas H Graham, Min Shu, Andreas Verras, Qing Chen, Margarita Garcia-Calvo

Bioorg Med Chem Lett· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and optimization of orally active cyclohexane-based prolylcarboxypeptidase (PrCP) inhibitors.
John S Debenham, Thomas H Graham, Andreas Verras, Yong Zhang, Matthew J Clements

Bioorg Med Chem Lett· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutagenesis and functional studies with succinate dehydrogenase inhibitors in the wheat pathogen Mycosphaerella graminicola.
Gabriel Scalliet, Judith Bowler, Torsten Luksch, Lucy Kirchhofer-Allan, Diana Steinhauer, Andreas Verras

PLoS One· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QSAR Prediction of Passive Permeability in the LLC-PK1 Cell Line: Trends in Molecular Properties and Cross-Prediction of Caco-2 Permeabilities.
Edward C Sherer, Andreas Verras, Maria Madeira, William K Hagmann, Robert P Sheridan

Mol Inform· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis